Stocks › RXN
RXN
RXN·USD
—
No end-of-day price on record
RXN
RXN
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
RXNS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of RXN by members of U.S. Congress · 6 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Gilbert Ray Cisneros, Jr.House · D · CA |
RXNRXN · Stock |
Sale $1,001 - $15,000 |
Aug 19, 2020 | Jul 21, 2020 | Filing ↗ |
| Gilbert Ray Cisneros, Jr.House · D · CA |
RXNRXN · Stock |
Sale $1,001 - $15,000 |
Aug 19, 2020 | Jul 22, 2020 | Filing ↗ |
| Gilbert Ray Cisneros, Jr.House · D · CA |
RXNRXN · Stock |
Purchase $1,001 - $15,000 |
May 14, 2019 | Apr 9, 2019 | Filing ↗ |
| Gilbert Ray Cisneros, Jr.House · D · CA |
RXNRXN · Stock |
Purchase $1,001 - $15,000 |
Apr 16, 2019 | Mar 15, 2019 | Filing ↗ |
 K. Michael ConawayHouse · R · TX |
RXNRXN · Stock |
Sale $1,001 - $15,000 |
Oct 12, 2016 | Sep 12, 2016 | Filing ↗ |
 Thomas MacArthurHouse · R · NJ |
RXNRXN · Stock |
Sale $1,001 - $15,000 |
Nov 3, 2015 | Oct 20, 2015 | Filing ↗ |
Whale Activity
Institutional 13F positions
No 13F positions in RXN among the institutional filers we track.
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by RXN insiders, by quarter · Form 4
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
522 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Chhabra SudhanshuVP-Rexnord Business Systems | Sale | −4,220 | $63.93 | $270K | Sep 10, 2021 | Form 4 ↗ |
| Chhabra SudhanshuVP-Rexnord Business Systems | Grant / award | +4,220 | $28.60 | $121K | Sep 10, 2021 | Form 4 ↗ |
| Chhabra SudhanshuVP-Rexnord Business Systems | Sale | −46.1K | $63.13 | $2.9M | Sep 9, 2021 | Form 4 ↗ |
| Chhabra SudhanshuVP-Rexnord Business Systems | Grant / award | +46.1K | $28.60 | $1.3M | Sep 9, 2021 | Form 4 ↗ |
| MOORE GEORGE CDirector | Gift | −7,500 | — | — | Sep 8, 2021 | Form 4 ↗ |
| Troutman MichaelChief Information Officer | Sale | −18.9K | $62.73 | $1.2M | Sep 8, 2021 | Form 4 ↗ |
| Stroup John SDirector | Sale | −10.3K | $63.07 | $651K | Sep 7, 2021 | Form 4 ↗ |
| Stroup John SDirector | Grant / award | +10.3K | $29.31 | $302K | Sep 7, 2021 | Form 4 ↗ |
| Zaba Kevin JGroup Ex., President-PMC | Sale | −18.2K | $63.16 | $1.2M | Sep 7, 2021 | Form 4 ↗ |
| Dua ChiragVP & Gen Mgr-Digital Solutions | Sale | −3,449 | $60.18 | $208K | Aug 23, 2021 | Form 4 ↗ |
| Dua ChiragVP & Gen Mgr-Digital Solutions | Sale | −4,056 | $60.20 | $244K | Aug 23, 2021 | Form 4 ↗ |
| Dua ChiragVP & Gen Mgr-Digital Solutions | Option exercise | +2,514 | $28.91 | $73K | Aug 23, 2021 | Form 4 ↗ |
| Dua ChiragVP & Gen Mgr-Digital Solutions | Option exercise | +1,542 | $23.13 | $36K | Aug 23, 2021 | Form 4 ↗ |
| Schooler RosemaryDirector | Grant / award | +443 | $50.88 | $23K | Jul 15, 2021 | Form 4 ↗ |
| CHRISTOPOUL THOMASDirector | Grant / award | +504 | $50.88 | $26K | Jul 15, 2021 | Form 4 ↗ |
| Troy PeggyDirector | Grant / award | +443 | $50.88 | $23K | Jul 15, 2021 | Form 4 ↗ |
| Jackson RodneySVP-Bus.&Corp. Development | Sale | −125.5K | $50.53 | $6.3M | Jun 4, 2021 | Form 4 ↗ |
| Jackson RodneySVP-Bus.&Corp. Development | Option exercise | +7,664 | $28.91 | $222K | Jun 4, 2021 | Form 4 ↗ |
| Jackson RodneySVP-Bus.&Corp. Development | Option exercise | +20.1K | $23.13 | $464K | Jun 4, 2021 | Form 4 ↗ |
| Jackson RodneySVP-Bus.&Corp. Development | Option exercise | +43.7K | $19.70 | $861K | Jun 4, 2021 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding RXN · SEC Form N-PORT
Funds report their holdings by CUSIP, and RXN could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming RXN as client
No lobbying filings found naming RXN as the client.
Government Contracts
Federal awards to RXN · USAspending
No federal contract awards found for RXN.
U.S. Patents
Recent USPTO applications naming RXN
No USPTO patent applications found for RXN.
Annual Financials
From RXN's 10-K filings · XBRL
No annual XBRL figures on record for RXN. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No price history on record for RXN.
Material Events (8-K)
Corporate events filed with the SEC
No 8-K filings on record.
About RXN
From SEC EDGAR company records
No company profile on record.